More Canadians to benefit from personalized cancer treatment

August 14, 2015

Personalized cancer treatment requires complex clinical laboratory testing to determine a tumour’s genetic profile. The Princess Margaret Cancer Centre, a leader in providing this testing for its patients, and LifeLabs Medical Laboratory Services have begun working together to expand this testing capacity to more Canadians. The Princess Margaret Cancer Centre (PMCC) has teamed up with…

Read More

Rising prices for new targeted therapeutics threatens their own success

August 14, 2015

One cancer drug alone could wipe out Canada’s total budget of $12B for prescription drugs. Can this last? Drug companies bringing out new targeted therapies for rare disorders are asking, and getting, eye-popping prices. Examples include Kalydeco® for one type of Cystic Fibrosis, reported to cost CAD$300,000 per year, or the recently marketed Solaris® for…

Read More